TY - JOUR
T1 - Factors Associated With Discordant A1C-Estimated and Measured Average Glucose Among Hospitalized Patients With Diabetes
AU - Wallam, Sara
AU - Abusamaan, Mohammed
AU - Clarke, William
AU - Mathioudakis, Nestoras
N1 - Publisher Copyright:
©2023 by the American Diabetes Association.
PY - 2023/3
Y1 - 2023/3
N2 - In this retrospective analysis, we explored the correlation between measured average glucose (mAG) and A1C-estimated average glucose (eAG) in hospitalized patients with diabetes and identified factors associated with discordant mAG and eAG at the transition from home to hospital. Having mAG lower than eAG was associated with Black race, other race, increasing length of stay, community hospital setting, surgery, fever, metformin use, certain inpatient diets, home antihyperglycemic treatment, and coded type 1 or type 2 diabetes. Having mAG higher than eAG was associated with certain discharge services (e.g., intensive care unit), higher BMI, hypertension, tachycardia, higher albumin, higher potassium, anemia, inpatient glucocorticoid use, and treatment with home insulin, secretagogues, and glucocorticoids. These factors should be considered when using patients’ A1C as an indicator of outpatient glycemic control to determine the inpatient antihyperglycemic regimens.
AB - In this retrospective analysis, we explored the correlation between measured average glucose (mAG) and A1C-estimated average glucose (eAG) in hospitalized patients with diabetes and identified factors associated with discordant mAG and eAG at the transition from home to hospital. Having mAG lower than eAG was associated with Black race, other race, increasing length of stay, community hospital setting, surgery, fever, metformin use, certain inpatient diets, home antihyperglycemic treatment, and coded type 1 or type 2 diabetes. Having mAG higher than eAG was associated with certain discharge services (e.g., intensive care unit), higher BMI, hypertension, tachycardia, higher albumin, higher potassium, anemia, inpatient glucocorticoid use, and treatment with home insulin, secretagogues, and glucocorticoids. These factors should be considered when using patients’ A1C as an indicator of outpatient glycemic control to determine the inpatient antihyperglycemic regimens.
UR - http://www.scopus.com/inward/record.url?scp=85163554813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85163554813&partnerID=8YFLogxK
U2 - 10.2337/cd22-0047
DO - 10.2337/cd22-0047
M3 - Article
C2 - 37092143
AN - SCOPUS:85163554813
SN - 0891-8929
VL - 41
SP - 208
EP - 219
JO - Clinical Diabetes
JF - Clinical Diabetes
IS - 2
ER -